ciglitazone and homocysteine
ciglitazone has been researched along with homocysteine in 5 studies
Research
Studies (5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Dai, J; Remick, DG; Wang, X; Zeng, X | 1 |
Lominadze, D; Moshal, KS; Ovechkin, AV; Tyagi, N; Tyagi, SC | 1 |
Lominadze, D; Moshal, KS; Ovechkin, AV; Sen, U; Tyagi, N; Tyagi, SC | 1 |
Aggrawal, D; Carneal, G; Kumar, M; Newsome, J; Rodriguez, WE; Sen, U; Tyagi, N; Tyagi, SC | 1 |
Kumar, M; Kundu, S; Rodriguez, WE; Sen, U; Tyagi, N; Tyagi, SC | 1 |
Other Studies
5 other study(ies) available for ciglitazone and homocysteine
Article | Year |
---|---|
Homocysteine mediated expression and secretion of monocyte chemoattractant protein-1 and interleukin-8 in human monocytes.
Topics: Antioxidants; Cells, Cultured; Chemokine CCL2; Chromans; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Gene Expression Regulation; Genistein; Homocysteine; Humans; Imidazoles; Indoles; Interleukin-8; Monocytes; Naphthalenes; Onium Compounds; Pyridines; Pyrrolidines; Reactive Oxygen Species; RNA, Messenger; Sulfonamides; Thiazoles; Thiazolidinediones; Thiocarbamates; Time Factors; Troglitazone; Tyrphostins | 2003 |
Homocysteine-dependent cardiac remodeling and endothelial-myocyte coupling in a 2 kidney, 1 clip Goldblatt hypertension mouse model.
Topics: Acetylcholine; Animals; Blotting, Western; Collagen; Endothelin-1; Endothelium, Vascular; Fibrosis; Homocysteine; Hypertension, Renovascular; Hypoglycemic Agents; Kidney; Male; Matrix Metalloproteinases; Mice; Mice, Inbred C57BL; Myocardial Contraction; Myocytes, Cardiac; Nitroprusside; PPAR gamma; Proteinuria; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tyrosine; Vasodilator Agents; Ventricular Remodeling | 2005 |
Ciglitazone ameliorates homocysteine-mediated mitochondrial translocation and matrix metalloproteinase-9 activation in endothelial cells by inducing peroxisome proliferator activated receptor-gamma activity.
Topics: Animals; Cells, Cultured; Electrophoresis, Gel, Two-Dimensional; Endothelial Cells; Enzyme Activation; Homocysteine; Hypoglycemic Agents; Matrix Metalloproteinase 9; Mice; Mitochondria; NADPH Oxidase 4; NADPH Oxidases; PPAR gamma; Reactive Oxygen Species; Thiazolidinediones; Thioredoxins | 2006 |
PPAR gamma agonist normalizes glomerular filtration rate, tissue levels of homocysteine, and attenuates endothelial-myocyte uncoupling in alloxan induced diabetic mice.
Topics: Alloxan; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Endothelium; Glomerular Filtration Rate; Homocysteine; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Muscle Cells; PPAR gamma; Thiazolidinediones | 2008 |
Ciglitazone, a PPARgamma agonist, ameliorates diabetic nephropathy in part through homocysteine clearance.
Topics: Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Epinephrine; Gene Expression; Glomerular Filtration Rate; Homocysteine; Hypoglycemic Agents; Kidney Tubules; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Mice; Mice, Inbred C57BL; Nitric Oxide; PPAR gamma; Renal Artery; Renal Circulation; Thiazolidinediones; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-4; Tissue Inhibitor of Metalloproteinases; Vascular Resistance; Vasoconstriction | 2008 |